Dalal AA - Search Results

1

Cost and utilization of COPD and asthma among insured adults in the US.

Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Blanchette CM, et al. Among authors: dalal aa. Curr Med Res Opin. 2009 Jun;25(6):1385-92. doi: 10.1185/03007990902875927. Curr Med Res Opin. 2009. PMID: 19419342

2

Adherence to controller therapy for chronic obstructive pulmonary disease: a review.

Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Charles MS, et al. Among authors: dalal aa. Curr Med Res Opin. 2010 Oct;26(10):2421-9. doi: 10.1185/03007995.2010.516284. Curr Med Res Opin. 2010. PMID: 20815661 Review.

3

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA. Simoni-Wastila L, et al. Among authors: dalal aa. Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157. Curr Med Res Opin. 2009. PMID: 19778165

4

Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.

Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Blanchette CM, et al. Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005. Am J Geriatr Pharmacother. 2008. PMID: 18775388

5

Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients.

Dalal AA, St Charles M, Petersen HV, Roberts MH, Blanchette CM, Manavi-Zieverink K. Dalal AA, et al. Int J Chron Obstruct Pulmon Dis. 2010 Aug 9;5:179-87. doi: 10.2147/copd.s10988. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 20714371 Free PMC article.

6

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW. Dalal AA, et al. Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 21311689 Free PMC article.

7

Economic burden of chronic bronchitis in the United States: a retrospective case-control study.

Blanchette CM, Roberts MH, Petersen H, Dalal AA, Mapel DW. Blanchette CM, et al. Among authors: dalal aa. Int J Chron Obstruct Pulmon Dis. 2011 Jan 13;6:73-81. doi: 10.2147/COPD.S15882. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21311695 Free PMC article.

8

Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.

Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT. Mapel DW, et al. Among authors: dalal aa. Int J Chron Obstruct Pulmon Dis. 2011;6:573-81. doi: 10.2147/COPD.S16975. Epub 2011 Nov 9. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 22135490 Free PMC article.

9

Changes in COPD demographics and costs over 20 years.

Blanchette CM, Dalal AA, Mapel D. Blanchette CM, et al. Among authors: dalal aa. J Med Econ. 2012;15(6):1176-82. doi: 10.3111/13696998.2012.713880. Epub 2012 Aug 1. J Med Econ. 2012. PMID: 22812689 Free article.

10

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM. Delea TE, et al. Among authors: dalal aa. Curr Med Res Opin. 2009 Jan;25(1):1-13. doi: 10.1185/03007990802534020. Curr Med Res Opin. 2009. PMID: 19210134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters